Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Kitano

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Neurology|June 12, 2016
Diagnostic utility of FDG-PET in neurolymphomatosis: report of five casesHisanori Kinoshita, Hodaka Yamakado, Toshiyuki Kitano, et al.
International Journal of Hematology|April 3, 2015
Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustineMomoko Nishikori, Toshiyuki Kitano, Masayuki Kobayashi, et al.
International Journal of Hematology|August 7, 2007
Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapyToshiyuki Kitano, Harue Tada, Tsutomu Nishimura, et al.
Internal Medicine (Tokyo, Japan)|June 13, 2012
A case of follicular lymphoma associated with paraneoplastic cerebellar degenerationYayoi Shimazu, Eiko N Minakawa, Momoko Nishikori, et al.
Oncology|December 15, 2010
Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOXYukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathySumie Hiramatsu, Koichiro Ohmura, Hideaki Tsuji, et al.
Cancer Science|September 13, 2016
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphomaDai Maruyama, Hirokazu Nagai, Noriko Fukuhara, et al.
Chemotherapy|September 11, 2008
Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome studyShigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, et al.
International Journal of Clinical Oncology|June 15, 2007
Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancerMasashi Kanai, Shigemi Matsumoto, Takahumi Nishimura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2009
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Neurology|June 12, 2016
Diagnostic utility of FDG-PET in neurolymphomatosis: report of five casesHisanori Kinoshita, Hodaka Yamakado, Toshiyuki Kitano, et al.
International Journal of Hematology|April 3, 2015
Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustineMomoko Nishikori, Toshiyuki Kitano, Masayuki Kobayashi, et al.
International Journal of Hematology|August 7, 2007
Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapyToshiyuki Kitano, Harue Tada, Tsutomu Nishimura, et al.
Internal Medicine (Tokyo, Japan)|June 13, 2012
A case of follicular lymphoma associated with paraneoplastic cerebellar degenerationYayoi Shimazu, Eiko N Minakawa, Momoko Nishikori, et al.
Oncology|December 15, 2010
Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOXYukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathySumie Hiramatsu, Koichiro Ohmura, Hideaki Tsuji, et al.
Cancer Science|September 13, 2016
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphomaDai Maruyama, Hirokazu Nagai, Noriko Fukuhara, et al.
Chemotherapy|September 11, 2008
Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome studyShigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, et al.
International Journal of Clinical Oncology|June 15, 2007
Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancerMasashi Kanai, Shigemi Matsumoto, Takahumi Nishimura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2009
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida, et al.
Pageof 8